Insider · CIK 0001792726

BASTA JAMES

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001792726

Forms 4 and 5

Insider transactions

25 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-02	NTLAIntellia Therapeutics, Inc.S Sale	EVP, General Counsel	SSale	−1,211 sh	$13.78	−$16.7K	156,794
2026-03-01	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	EVP, General Counsel	AAward	+65.8K sh	—	—	65,829
2026-03-01	NTLAIntellia Therapeutics, Inc.A Award	EVP, General Counsel	AAward	+46.1K sh	—	—	158,005
2026-01-05	NTLAIntellia Therapeutics, Inc.S Sale	EVP, General Counsel	SSale	−10.4K sh	$9.21	−$95.8K	101,528
2025-03-04	NTLAIntellia Therapeutics, Inc.S Sale	EVP, General Counsel	SSale	−2,572 sh	$8.99	−$23.1K	111,925
2025-03-01	NTLAIntellia Therapeutics, Inc.A Award	EVP, General Counsel	AAward	+40K sh	—	—	114,497
2025-03-01	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	EVP, General Counsel	AAward	+57.1K sh	—	—	57,143
2025-01-03	NTLAIntellia Therapeutics, Inc.S Sale	EVP, General Counsel	SSale	−7,074 sh	$12.18	−$86.2K	74,497
2024-03-04	NTLAIntellia Therapeutics, Inc.S Sale	EVP, General Counsel	SSale	−2,297 sh	$32.99	−$75.8K	81,571
2024-03-01	NTLAIntellia Therapeutics, Inc.A Award	EVP, General Counsel	AAward	+32.4K sh	—	—	83,868
2024-03-01	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	EVP, General Counsel	AAward	+46.8K sh	—	—	46,752
2024-01-03	NTLAIntellia Therapeutics, Inc.S Sale	EVP, General Counsel	SSale	−3,805 sh	$29.46	−$112K	51,474
2023-03-02	NTLAIntellia Therapeutics, Inc.S Sale	EVP, General Counsel	SSale	−1,088 sh	$43.88	−$47.7K	55,279
2023-03-01	NTLAIntellia Therapeutics, Inc.A Award	EVP, General Counsel	AAward	+12.3K sh	—	—	56,367
2023-03-01	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	EVP, General Counsel	AAward	+34.7K sh	—	—	34,674
2023-03-01	NTLAIntellia Therapeutics, Inc.A Award	EVP, General Counsel	AAward	+24.5K sh	—	—	44,098
2023-01-04	NTLAIntellia Therapeutics, Inc.S Sale	EVP, General Counsel	SSale	−1,138 sh	$37.21	−$42.3K	19,559
2022-03-01	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	EVP, General Counsel	AAward	+14.1K sh	—	—	14,109
2022-03-01	NTLAIntellia Therapeutics, Inc. · Stock Option (right to buy)A Award	EVP, General Counsel	AAward	+9,648 sh	—	—	9,648
2022-03-01	NTLAIntellia Therapeutics, Inc.A Award	EVP, General Counsel	AAward	+9,648 sh	—	—	20,697
2022-03-01	NTLAIntellia Therapeutics, Inc.A Award	EVP, General Counsel	AAward	+11K sh	—	—	11,049
2021-07-01	NTLAIntellia Therapeutics, Inc. · Stock Option (Right to Buy)A Award	EVP, General Counsel	AAward	+130K sh	—	—	130,000
2021-01-26	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Chief Legal Officer	AAward	+125K sh	—	—	125,000
2020-03-12	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Chief Legal Officer	AAward	+25K sh	—	—	25,000
2019-11-04	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Chief Legal Officer	AAward	+175K sh	—	—	175,000

Recent filings

Accepted (ET)
Mar 34
BASTA JAMES0001193125-26-088260
SEC(opens sec.gov)
Jan 74
BASTA JAMES0001193125-26-006291
SEC(opens sec.gov)
Mar 44
BASTA JAMES0000950170-25-032086
SEC(opens sec.gov)
Jan 74
BASTA JAMES0000950170-25-003028
SEC(opens sec.gov)
Mar 54
BASTA JAMES0000950170-24-025906
SEC(opens sec.gov)
Jan 54
BASTA JAMES0000950170-24-002504
SEC(opens sec.gov)
Mar 34
BASTA JAMES0001209191-23-015722
SEC(opens sec.gov)
Jan 64
BASTA JAMES0001209191-23-002410
SEC(opens sec.gov)
Mar 44/A
BASTA JAMES0001209191-22-016539
SEC(opens sec.gov)
Mar 34
BASTA JAMES0001209191-22-015909
SEC(opens sec.gov)

Companies

Address

C/O INTELLIA THERAPEUTICS, INC. 40 ERIE STREET; SUITE 130

CAMBRIDGE, MA, 02139